04-04-2025 16:58 via drugs.com

AI Improves Risk Prediction in Patients With Myelofibrosis Undergoing Allo-HCT

FRIDAY, April 4, 2025-- For patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (allo-HCT), machine learning (ML) enhances risk stratification, according to a study published online March 27 in Blood.Juan Carlos...
Read more »

Pharmaceutical news



American College of Cardiology, March 29-31
ACP: Switching From Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DM
Judge Blocks Cuts to $11 Billion in Public Health Funding
Greater Wealth Linked to Lower Mortality, With Stronger Link in U.S.
Preop Macular Thickness May Be Marker of Postop Delirium in Seniors
Study Quantifies Breast Shrinkage After T1 Tumor Lumpectomy
Alteplase Increases Frequency of Functional Independence After Posterior Circulation Stroke
2005 to 2019 Saw Increase in Incidence of Cervical Artery Dissection
Rise in Prevalence of Obesity in Youth, Adults With T1DM Seen From 2008 to 2023
Common Chemicals in Plastics May Harm Baby Brain Development
Trump Administration Orders More Cuts to CDC Budget
FDA Delays Final Approval of Novavax COVID Vaccine
Medicaid Expansion Protected Americans During COVID-19 Pandemic
Antidepressants Linked To Sudden Cardiac Death
Desktop versie